@vasyoungcom.bsky.social
#VAS2025
It's time to put the patients on our focus, and what better way to do it than including them in one of the congress sessions?
Nurse, nephrologist, surgeon, radiologist and the patients, all in one spot, to solve our patient's questions.
It's time to put the patients on our focus, and what better way to do it than including them in one of the congress sessions?
Nurse, nephrologist, surgeon, radiologist and the patients, all in one spot, to solve our patient's questions.
April 5, 2025 at 8:28 AM
#VAS2025
It's time to put the patients on our focus, and what better way to do it than including them in one of the congress sessions?
Nurse, nephrologist, surgeon, radiologist and the patients, all in one spot, to solve our patient's questions.
It's time to put the patients on our focus, and what better way to do it than including them in one of the congress sessions?
Nurse, nephrologist, surgeon, radiologist and the patients, all in one spot, to solve our patient's questions.
#VAS2025
Bostjan Leskovar (SLO) and his team compared side to side anastomosis with end-to-side AVF creation:
🚨Less vein manipulation
🚨Less juxta-anastomotic stenosis
🚨Better primary and primary assisted patency
🚨Less radial art thrombosis
⌚Comparable operating time
Bostjan Leskovar (SLO) and his team compared side to side anastomosis with end-to-side AVF creation:
🚨Less vein manipulation
🚨Less juxta-anastomotic stenosis
🚨Better primary and primary assisted patency
🚨Less radial art thrombosis
⌚Comparable operating time
April 5, 2025 at 7:49 AM
#VAS2025
Bostjan Leskovar (SLO) and his team compared side to side anastomosis with end-to-side AVF creation:
🚨Less vein manipulation
🚨Less juxta-anastomotic stenosis
🚨Better primary and primary assisted patency
🚨Less radial art thrombosis
⌚Comparable operating time
Bostjan Leskovar (SLO) and his team compared side to side anastomosis with end-to-side AVF creation:
🚨Less vein manipulation
🚨Less juxta-anastomotic stenosis
🚨Better primary and primary assisted patency
🚨Less radial art thrombosis
⌚Comparable operating time
Dr Claudio Ronco reminded us, younger generations, that there is still a lot to be done for vascular access. The only way forward is to keep on researching and keep our curiosity alive
#VAS2025
#VAS2025
April 5, 2025 at 7:36 AM
Dr Claudio Ronco reminded us, younger generations, that there is still a lot to be done for vascular access. The only way forward is to keep on researching and keep our curiosity alive
#VAS2025
#VAS2025
Last day at #VAS2025 and it starts with no other than Dr Claudio Ronco. Really interesting talk about the history of hemodialysis and vascular access
April 5, 2025 at 7:10 AM
Last day at #VAS2025 and it starts with no other than Dr Claudio Ronco. Really interesting talk about the history of hemodialysis and vascular access
How cost-effective are really endoAVFs? José Ibeas explains more data and experience are needed since 5-year model outcomes shows surgical AVFs are still the better option.
#VAS2025
#VAS2025
April 4, 2025 at 11:49 AM
How cost-effective are really endoAVFs? José Ibeas explains more data and experience are needed since 5-year model outcomes shows surgical AVFs are still the better option.
#VAS2025
#VAS2025
Updates on endoAVFs, now at #VAS2025! What is new?:
-Ellipsis (thermal-based): 1 cannulation site. US needed.
-WavelinQ (radiofrequency): allows for multiple cannulation sites. Fluoroscopy needed.
-Other options in development: ePATH (BMS as anastomosis) and Velocity.
-Ellipsis (thermal-based): 1 cannulation site. US needed.
-WavelinQ (radiofrequency): allows for multiple cannulation sites. Fluoroscopy needed.
-Other options in development: ePATH (BMS as anastomosis) and Velocity.
April 4, 2025 at 11:27 AM
Updates on endoAVFs, now at #VAS2025! What is new?:
-Ellipsis (thermal-based): 1 cannulation site. US needed.
-WavelinQ (radiofrequency): allows for multiple cannulation sites. Fluoroscopy needed.
-Other options in development: ePATH (BMS as anastomosis) and Velocity.
-Ellipsis (thermal-based): 1 cannulation site. US needed.
-WavelinQ (radiofrequency): allows for multiple cannulation sites. Fluoroscopy needed.
-Other options in development: ePATH (BMS as anastomosis) and Velocity.
It's one of the best moments of the #VAS2025 congress: it's clinical case time! Discussion of BMS on dialysis patients, endoAVF fistula's reinterventions and its complications:
April 4, 2025 at 9:54 AM
It's one of the best moments of the #VAS2025 congress: it's clinical case time! Discussion of BMS on dialysis patients, endoAVF fistula's reinterventions and its complications:
The VAS awards have been published! We're happy to announced that one of them has been given to one of our young committee members. We're really excited for what the future is holding for the rest of the VA community #VAS2025
April 4, 2025 at 7:50 AM
The VAS awards have been published! We're happy to announced that one of them has been given to one of our young committee members. We're really excited for what the future is holding for the rest of the VA community #VAS2025
John Lucas III shows us the different approaches to correction of the flow of fistulas according to its severity and presence of symptoms, specifically, distal ischemia
#VAS2025
#VAS2025
April 3, 2025 at 3:00 PM
John Lucas III shows us the different approaches to correction of the flow of fistulas according to its severity and presence of symptoms, specifically, distal ischemia
#VAS2025
#VAS2025
Prabir Roy-Chaudhury reminds us of how our patient's VA might be underestimated, even by us and our colleagues, while he reminds us of possible newer technologies available to our use
#VAS2025
#VAS2025
April 3, 2025 at 8:18 AM
Prabir Roy-Chaudhury reminds us of how our patient's VA might be underestimated, even by us and our colleagues, while he reminds us of possible newer technologies available to our use
#VAS2025
#VAS2025
Article of the month📣 Interesting retrospective cohort study from Japan🤔! Showing that femoro-femoral arteriovenous fistulas can be a viable and durable option when traditional access points are no longer feasible!
jvascsurg.org/article/S0741-…
jvascsurg.org/article/S0741-…
March 11, 2025 at 7:52 AM
Article of the month📣 Interesting retrospective cohort study from Japan🤔! Showing that femoro-femoral arteriovenous fistulas can be a viable and durable option when traditional access points are no longer feasible!
jvascsurg.org/article/S0741-…
jvascsurg.org/article/S0741-…
🌟 Welcome to VAS Young Committee!🌟 Join us as we dive into the world of vascular access for dialysis, connecting young professionals with latest insights, innovations, and opportunities. Stay tuned for expert tips and inspiring stories.#YoungProfessionals #VascularAccessSociety
March 11, 2025 at 7:52 AM
🌟 Welcome to VAS Young Committee!🌟 Join us as we dive into the world of vascular access for dialysis, connecting young professionals with latest insights, innovations, and opportunities. Stay tuned for expert tips and inspiring stories.#YoungProfessionals #VascularAccessSociety